NANOFORM Trademark

Trademark Overview


On Friday, July 29, 2016, a trademark application was filed for NANOFORM with the United States Patent and Trademark Office. The USPTO has given the NANOFORM trademark a serial number of 87121316. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 4, 2019. This trademark is owned by Sigmoid Pharma Limited. The NANOFORM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

(Based on 44(e)) (Based on Intent to Use) pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders; (Based on Intent to Use) Pharmaceutical and veterinary preparations and substances for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders

(Based on 44(e)) (Based on Intent to Use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; medical research relating to the diagnosis and treatment of disease involving the use of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; (Based on Intent to Use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances; medical research relating to the diagnosis and treatment of disease; medical research on the efficacy of pharmaceutical and v...
nanoform

General Information


Serial Number87121316
Word MarkNANOFORM
Filing DateFriday, July 29, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 4, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements


Goods and Services(Based on 44(e)) (Based on Intent to Use) pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders; (Based on Intent to Use) Pharmaceutical and veterinary preparations and substances for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders
Goods and Services(Based on 44(e)) (Based on Intent to Use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; medical research relating to the diagnosis and treatment of disease involving the use of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; (Based on Intent to Use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances; medical research relating to the diagnosis and treatment of disease; medical research on the efficacy of pharmaceutical and veterinary preparations and substances; medical and scientific research, namely, conducting clinical trials involving pharmaceutical and veterinary preparations and substances

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 3, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 3, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSigmoid Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin 9
IE

Party NameSigmoid Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin 9
IE

Trademark Events


Event DateEvent Description
Monday, February 4, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 4, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 7, 2018EXTENSION 1 GRANTED
Thursday, June 7, 2018EXTENSION 1 FILED
Thursday, June 7, 2018TEAS EXTENSION RECEIVED
Tuesday, January 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2017ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 29, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, September 22, 2017ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 15, 2017ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, September 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 11, 2017EXAMINER'S AMENDMENT ENTERED
Monday, September 11, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, September 11, 2017EXAMINERS AMENDMENT E-MAILED
Monday, September 11, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, August 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 10, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 10, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 8, 2017NON-FINAL ACTION E-MAILED
Monday, May 8, 2017NON-FINAL ACTION WRITTEN
Thursday, April 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 13, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 10, 2017ASSIGNED TO LIE
Monday, March 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 15, 2016NON-FINAL ACTION E-MAILED
Tuesday, November 15, 2016NON-FINAL ACTION WRITTEN
Wednesday, November 9, 2016ASSIGNED TO EXAMINER
Wednesday, August 3, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 2, 2016NEW APPLICATION ENTERED IN TRAM